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Abstract
Thymosin beta-4 (Tb4) is an ubiquitous multi-functional regenerative peptide, related to many critical biological processes,
with a dynamic and flexible conformation which may influence its functions and its subcellular distribution. For these
reasons, the intracellular localization and trafficking of Tb4 is still not completely defined and is still under investigation in in
vivo as well as in vitro studies. In the current study we used HepG2 cells, a human hepatoma cell line; cells growing in
normal conditions with fetal bovine serum expressed high levels of Tb4, restricted to the cytoplasm until 72 h. At 84 h, a
diffuse Tb4 cytoplasmic immunostaining shifted to a focal perinuclear and nuclear reactivity. In the absence of serum,
nuclear reactivity was localized in small granules, evenly dispersed throughout the entire nuclear envelop, and was
observed as earlier as at 48 h. Cytoplasmic immunostaining for Tb4 in HepG2 cells under starvation appeared significantly
lower at 48 h and decreased progressively at 72 and at 84 h. At these time points, the decrease in cytoplasmic staining was
associated with a progressive increase in nuclear reactivity, suggesting a possible translocation of the peptide from the
cytoplasm to the nuclear membrane. The normal immunocytochemical pattern was restored when culture cells submitted
to starvation for 84 h received a new complete medium for 48 h. Mass spectrometry analysis, performed on the nuclear
and cytosolic fractions of HepG2 growing with and without serum, showed that Tb4 was detectable only in the cytosolic
and not in the intranuclear fraction. These data suggest that Tb4 is able to translocate from different cytoplasmic domains
to the nuclear membrane and back, based on different stress conditions within the cell. The punctuate pattern of nuclear
Tb4 immunostaining associated with Tb4 absence in the nucleoplasm suggest that this peptide might be localized in the
nuclear pores, where it could regulate the pore permeability.
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Introduction
Thymosin beta-4 (Tb4) is a naturally occurring peptide, first
isolated in 1966 [1], containing 43 amino acid residues [2]. Tb4
activity has been mainly related to the regulation of actin
polymerization in living cells [3], acting as an actin-sequestering
peptide in mammalian cells [4]. In recent years, Tb4 has been
proposed as a multi-functional regenerative peptide [5], being
involved in many critical biological activities, including angio-
genesis [6], wound healing [7], inflammatory response [8] and
cell migration and survival [9]. In colon carcinoma cells, over-
expression of Tb4 has been associated with resistance to
apoptosis, via down-regulating Fas and up-regulating surviving
genes [10]. In another study, it was shown that Tb4 is able to
regulate induced-proinflammatory cytokine, blocking RelA/p65
nuclear translocation [11]. Tb4 may also have activities
independent from the G-actin-binding properties and its
dynamic, unstructured and flexible conformation seems to be
determinant. [12].
To better understand the role of its small peptide, several
studies have analyzed in detail his intracellular localization. In
resting macrophages, immunoreactivity for Tb4 was found to be
restricted to the cytoplasm, in the absence of any nuclear
immunostaining [13]. Labelled Tb4 injected into Xenopus laevis
oocytes was equally distributed between the cytoplasmatic and
nuclear compartments [14]. In the human mammary carcinoma
MCF-7 cell line, a variable Tb4 cytoplasmic immunoreactivity,
was found constantly associated with an additional nuclear
staining [15]. Experiments with microinjection of two fluores-
cently labeled Tb4 fragments into HeLa cells supported the
hypothesis of the existence of specific active transport mecha-
nisms regulating translocation of this peptide into the cell
nucleus [15].
In another study, polyamine depletion in migrating IEC-6 cells
induced a translocation of Tß4 into the nucleus [16].
On the contrary, another study using different Tb4 variants,
underlined a possible passive but regulated diffusion that might
shuttle this peptide into the nucleus, suggesting that Tb4
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translocation could be regulated by the change of the pore
permeability [17].
Recently, Tb4 has been reported to be expressed in high levels
in normal and neoplastic hepatocytes [18]. On the basis of these
data, it seemed of some interest to study the immunoreactivity of
Tb4 in HepG2 cells, a human hepatoma cell line with a strong
Tb4 immunocytochemistry expression, frequently used as an in
vitro model to investigate the regulation of hepatocytes cells
growth. [19–22]. In the current study, HepG2 cells were cultured
with complete medium or without fetal bovine serum, in order to
better analyze the Tb4 expression pattern and Tb4 localization
during different environmental conditions.
Materials and Methods
Cell culture
Commercial human cell line HepG2 (ICLC HTL95005), were
obtained from the Istituto Nazionale per la Ricerca sul Cancro c/o
CBA (ICLC, Genova). The culture medium used for this purpose
was a mixture of MEM (EBSS), 10% fetal bovine serum (FBS), 100
units/ml penicillin, 100 mg/ml streptomycin, 2 mM L-Glutamine,
1% non-essential amino acids. To perform different experimental
conditions, confluent cells were isolated using trypsin/EDTA and,
for the experimental procedure, samples of 2–36104 cells/cm2
HepG2 cells were plated on different glass coverslips at 37uC, 5%
CO2. After 24 h of growth with complete medium, cells were
cultured with complete culture medium or with medium without
FBS for 48 h, 72 h and 84 h. In cells submitted to serum
starvation for 84 h complete medium with FBS was added and
cells were analyzed at 24 and 48 h. All samples were washed with
PBS and fixed with acetone for 20 min, air dried for 30 min and
then stored at 220uC.
Tb4 immunocytochemistry
Tb4 immunocytochemistry was performed as previously
reported in human liver biopsies [18]. Briefly, cells were
rehydrated, and endogenous peroxidase activity was quenched
(3 min) by 0.3% hydrogen peroxide in methanol. Cells were
incubated with 10% normal goat serum in phosphate buffered
saline (PBS) for 5 min to block non-specific binding and then
incubated (30 min) with a polyclonal anti-Tß4 antibody (Bachem-
Peninsula Lab, San Carlos, CA, USA) diluted 1:100 in a blocking
solution. Cells were extensively washed with PBS containing
0.01% Triton X-100 and incubated with a secondary reagent
(Envision kit) according to the manufacturer’s instructions (Dako,
Glostrup, Denmark). After additional washes, color was developed
using AEC reagent (Dako, Glostrup, Denmark); cells were
counterstained with hematoxylin and mounted.
Cell fractionation
The modified method of Galan et al [23] was applied for cell
fractionation. Briefly, cells (46107 cells/mL) were incubated for
15 min in 2 mL of ice-cold buffer A (10 mM HEPES pH 7.9,
10 mM KCl, 0,1 mM EDTA, 0.1 mM EGTA, 1 mM DTT and
Complete Protease Inhibitor Cocktail (Roche, Basel, Switzerland),
1 tablet/10 mL) and then shaken vigorously for 2 min before
adding b-octyl-glucopyranoside (0.1% final concentration). The
cytosolic fraction was separated from nuclei by centrifugation at
13006g, 4uC, for 5 min, and stored at 280uC. The nuclear pellet
was washed twice in buffer A and then resuspended in buffer B
(20 mM HEPES pH 7.9, 0.4 mM NaCl, 1.0 mM EDTA, 1.0 mM
EGTA, 1 mM DTT and 1 tablet/10 mL of Complete Protease
Inhibitor Cocktail), rotated at 4uC for 15 min and then centrifuged
at 10006g for 5 min. The supernatant (nuclear fraction) was
collected and stored at 280uC.
Treatment of cytosolic and nuclear fractions and RP-
HPLC-ESI-MS analysis
Cytosolic and nuclear proteins/peptides were fractionated (30
KDa cut-off) with Amicon centrifugal filter units (Millipore,
Billerica, MA, USA), dialyzed in 25 mM sodium acetate pH 4.2
and then lyophilized. The lyophilized powder was dissolved in
120 mL of 0.1% aqueous trifluoroacetic acid (TFA), and the
solution centrifuged at 80006g for 10 min at 4uC. 100 mL of the
supernatant was injected in the RP-HPLC-ESI-MS apparatus.
HPLC-ESI-MS measurements were carried out by a Surveyor
HPLC system (ThermoFisher, San Jose, CA, USA) connected by a
T splitter to a photodiode-array detector and an LCQ Advantage
mass spectrometer (ThermoFisher). The chromatographic column
was a Vydac (Hesperia, CA, USA) C8 with 5 mm particle diameter
(column dimensions 15062.1 mm). The following solutions were
utilized for the chromatographic separations: (eluent A) 0.056%
aqueous TFA and (eluent B) 0.050% TFA in acetonitrile-water
80/20 (v/v). The applied gradient was linear from 0 to 54% in
39 min (linear) and from 54% to 100% in 10 min (linear), at a flow
rate of 0.30 mL/min. The T splitter permitted 0.20 mL/min to
flow toward the diode array detector and 0.10 mL/min toward
the ESI source. The photodiode array detector was set at a
wavelength of 214 and 276 nm. During the first 5 min of
separation eluate was not analized by the mass spectrometer in
order to avoid source contamination and instrument damage due
to the high salt concentration. Mass spectra were collected every 3
millisecond in the positive ion mode. MS spray voltage was 5.0 kV
and capillary temperature was 255uC.
HPLC-ESI-MS data analysis and quantification
The experimental average mass value of Thymosin b4,
previously characterized and previously reported by our labora-
tory [24], was obtained by deconvolution of ESI-MS spectra
automatically performed using MagTran 1.0 software [25] and
compared with the theoretical mass value, available at the Swiss-
Prot Data Bank (http://us.expasy.org/tools) with the accession
code P62328.
Quantification was based on the area of the RP-HPLC-ESI-MS
eXtracted Ion Current (XIC) peak, which is proportional to the
peptide/protein concentration under constant analytical condi-
tions [26]. The ions used to quantify the Tb4 were: 993.80 (+5),
1241.90 (+4) and 1655.50 (+3) m/z. A window of 60.5 Da was
used to extract ion chromatograms. The following post-transla-
tional modifications of the Tb4 were also searched in the
chromatogram: Tb4 sulfoxide, Tb4 acetylated at the level of
lateral chains, Tb4 phosphorylated.
Results
Immunocytochemistry expression
Tb4 immunocytochemistry of HepG2 cells growing in normal
conditions and after starvation was performed at 48 h, 72 h and
84 h.
HepG2 cells growing in complete medium for 48 h showed high
levels of Tb4 expression. Immunoreactivity for the peptide was
detected in the cytoplasm of the vast majority of culture cells,
appearing as small granules probably reflecting localization of the
peptide in cytoplasmic vacuoles (Fig. 1a). Tb4 expression was
evenly distributed throughout each single sample. No significant
differences, regarding the degree of immunostaining for Tb4 were
observed in HepG2 cells growing with complete medium (Fig. 1a,
Thymosin Beta-4 in HepG2 Cells under Starvation
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1b). At high power, reactivity for the peptide was restricted to the
cytoplasm of culture cells, in the absence of any nuclear
immunostaining (Fig. 1b). The pattern of immunoreactivity for
Tb4 changed in cells undergoing mitosis, being characterized by a
diffuse homogeneous cytoplasmic staining and in the absence of
any granular reactivity (Fig. 1b).
On the contrary, HepG2 cells growing for 48 h in the absence
of fetal bovine serum were characterized by an apparent reduction
in the degree of Tb4 expression. The peptide was mainly detected
in the cytoplasm of culture cells in a granular pattern, but the
intensity of immunostaining was significantly lower as compared to
HepG2 cells growing in complete medium (Fig. 1c). Moreover,
under starvation, immunoreactivity for Tb4 was also detected at
the nuclear level: nuclear staining for the peptide was localized in
granules organized as small roundish spots, evenly dispersed only
throughout the entire nuclear envelop (Fig. 1c, 1d). The peculiar
pattern of Tb4 reactivity previously described in mitotic figures
was confirmed even in cells growing in the absence of FBS: in
mitotic cells immunoreactivity for Tb4 was restricted to the
cytoplasm with a homogeneous staining pattern (Fig. 1d).
At this time point, HepG2 cells growing for 72 h in complete
medium were characterized by a higher immunoreactivity for Tb4
(Fig. 2a). Staining for the peptide was observed in the vast majority
of cells, always restricted to the cytoplasm. Fine and coarse Tb4-
reactive granules were observed scattered throughout the whole
cytoplasm. At high power, cells in mitosis showed, even at this time
point, an homogeneous cytoplasmic reactivity (Fig. 2b).
Occasionally, cells showed a different pattern of reactivity for
Tb4, characterized by a perinuclear spot, suggestive for a
localization of the peptide in the trans-Golgi network (Fig. 2b).
Marked differences in the immunocytochemical pattern were
detected at 72 h in culture cells under serum deprivation. The
degree of immunoreactivity appeared much lower, as compared to
cells growing with a complete medium. Moreover, immunostain-
ing for Tb4 was unevenly distributed, with positive cells
intermingled with negative cells (Fig. 2c). Cells undergoing
apoptosis, morphologically characterized by cell shrinkage and
chromatin condensation, were characterized by a strong homo-
geneous cytoplasmic staining, probably reflecting cell shrinkage
(Fig. 2c). Even at nuclear level, reactivity for Tb4 was uneven:
some cells showed a strong nuclear staining (Fig. 2c) appearing as
multiple roundish spots diffuse to the entire nuclear envelope.
Other cells did not show any nuclear reactivity for the peptide
(Fig. 2d). Marked differences regarding Tb4 expression were also
found, at this time point, in mitotic cells: the homogeneous pattern
previously described was substituted by a granular immunoreac-
tivity, always restricted to the cytoplasm (Fig. 2d).
Immunoreactivity for Tb4 changed significantly in cells growing
in complete medium for 84 h. First of all, we observed a decrease
in cytoplasmic immunostaining for the peptide, associated with its
uneven distribution (Fig. 3a). Moreover, we detected marked
changes in the localization of Tb4, which appeared to be mainly
localized in a perinuclear spot (Fig. 3a, 3b). At this time point, for
the first time, we observed immunoreactivity for Tb4 in the
nuclear envelop in cells growing in complete medium (Fig. 3a,
insert). This nuclear immunoreactivity was detected in a minority
of culture cells, whereas the vast majority of HepG2 cells showed a
predominant perinuclear cytoplasmic immunostaining (Fig. 3b).
After 84 h of serum deprivation, the highest levels of reactivity
for Tß4 were observed in the cytoplasm of cells undergoing
apoptosis, contrasting with a weak immunostaining in the
surviving cells (Fig. 3c, 3d). The marked decrease in cytoplasmic
immunostaining for Tß4 was paralleled by the increase in nuclear
reactivity, which was localized, as previously described, in the
nuclear envelope (Fig. 3c, insert).
When the medium was removed in cells submitted to starvation
for 84 h, and a new complete medium with serum was added,
24 h later we detected significant changes in Tb4 immunoreac-
tivity (Fig. 4a, 4b). At this time point, the peptide appeared evenly
distributed in the cytoplasm of the vast majority of cells (Fig. 4a).
After serum implementation, mitotic cells with a weak homoge-
Figure 1. Thymosin b 4 immunoreactivity after 48 h of
starvation. Tb 4 immunoreactivity in HepG2 cells cultured for 48 h
with serum (A and B, magnification 10006) and without serum (C and
D, magnification 10006). Inserts in A and in C represent one particular
of the intranuclear reactivity of the respective pictures (magnification
10006).
doi:10.1371/journal.pone.0067999.g001
Figure 2. Thymosin b 4 immunoreactivity after 72 h of
starvation. Tb 4 immunoreactivity in HepG2 cells cultured for 72 h
with serum (A and B, magnification 10006) and without serum (C and
D, magnification respectively 400 and 10006). Inserts in A and in C
represent one particular of the intranuclear reactivity of the respective
pictures (magnification 10006).
doi:10.1371/journal.pone.0067999.g002
Thymosin Beta-4 in HepG2 Cells under Starvation
PLOS ONE | www.plosone.org 3 August 2013 | Volume 8 | Issue 8 | e67999
neous immunoreactivity in the entire cytoplasm increased.
(Fig. 4b). Tb4 immunostaining, at this time point was also
detected in the nuclear envelope of a large number of culture cells
(Fig. 4a, insert).
A progressive increase in immunostaining for Tb4 was evident
in cells 48 h after introducing fresh medium. At this time point, the
peptide appeared evenly distributed, immunoreactivity being
mainly localized in the cytoplasm of the vast majority of cells
(Fig. 4c). At higher power, marked changes were detected
regarding the subcellular localization of Tb4: the peptide moved
from the nucleus towards the cytoplasm, leaving the nucleus
devoid of Tb4 (Fig. 4c, insert).
Mass spectrometry analysis
The cytosolic and nuclear fractions of HepG2 cells grown for
48 h under normal conditions and after starvation were
analyzed by HPLC-ESI-MS. Tb4 was detected only in the
cytosolic fractions (CF). The chromatographic position (19.3–
19.8 min), the experimental average mass value (4963.26
0.5 Da) and MS/MS spectrum perfectly corresponded with
the data registered on a standard sample of Tb4. The Fig. 5
reports results of XIC search of Tb4 in the cytosolic and nuclear
fractions (NF) under the two experimental conditions. The level
of Tb4 was not different in normal and stressed conditions CFs.
The known post-translational modified derivatives of Tb4 were
not detected in any samples.
Figure 3. Thymosin b 4 immunoreactivity after 84 h of
starvation. Tb 4 immunoreactivity in HepG2 cells cultured for 84 h
with serum (A and B, magnification 10006) and without serum (C and
D, magnification 10006). Inserts in A and in C represent one particular
of the intranuclear reactivity of the respective pictures (magnification
10006).
doi:10.1371/journal.pone.0067999.g003
Figure 4. Thymosin b 4 immunoreactivity 24 and 48 h with
complete medium after starvation. Tb 4 immunoreactivity in
HepG2 cells cultured for 84 h without serum and shifted in complete
medium for 24 h (A and B, magnification 4006) and for 48 h (C and D,
magnification 4006). Inserts in A and in C represent one particular of
the intranuclear reactivity of the respective pictures (magnification
10006).
doi:10.1371/journal.pone.0067999.g004
Figure 5. XIC peak of Tb4 evidenced by HPLC-ESI-MS analysis
of the cytosolic (CF) and nuclear fractions (NF) of HepG2 cells
grown for 48 h. Enlargements of the chromatographic profiles in the
range 17.4–21.1 min are reported. Tb4 search in CF of the cells grown
under starvation and normal conditions, panel A and panel B; Tb4
search in NF of the cells grown under starvation and normal conditions,
panel C and panel D; arrows indicate the absence of the Tb4 in its
chromatographic elution range.
doi:10.1371/journal.pone.0067999.g005
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Discussion
The data presented in this study demonstrate that HepG2 cells
normally express high levels of Tb4, which may be easily
identifiable by immunocytochemistry. As a consequence, HepG2
cells may be considered a reliable and useful model for the study of
Tb4 expression in human hepatocytes in different environmental
conditions, and should be added to the list of Tb4-producing cell
lines previously reported by Hannappel et al [27].
Our study reinforces the hypothesis on the ‘‘enigma’’ [28] of
beta- thymosins, by adding new interesting peculiar features to this
fascinating peptide: its ability to change conformation and to
translocate from one cytoplasmic domain to another, and from the
cytoplasm to the nucleus and back, according with different
environmental stimuli. In physiological situations, here represent-
ed by culture cells growing in fresh complete medium, Tb4 was
always restricted to the cytoplasm, showing a granular pattern
highly suggestive for its localization in cytoplasmic vacuoles. This
immunostaining has been observed without significant changes for
72 h, in the complete absence of any nuclear immunoreactivity. A
similar immunohistochemical pattern has been recently reported
by our group in the normal human liver: in that study, the
hepatocytes showed a strong granular immunoreactivity for Tb4,
which was stored in vacuoles irregularly dispersed throughout the
entire cytoplasm [18].
At 84 h, a time point in which culture cells become under
stress due to scarcity of nutrients and accumulation of waste
metabolic products, significant modifications in the Tb4
subcellular localization were found. The previously reported
diffuse cytoplasmic immunostaining was substituted by a focal
reactivity, mainly represented by a perinuclear spot-like staining
pattern highly suggestive of a translocation of Tb4 from
vacuoles towards the trans-Golgi network. A similar cytoplasmic
localization of Tb4 has been previously observed by our group
in the human normal colon mucosa, in the proximity of colon
cancer [29]. In that study, Tb4-immunoreactive perinuclear
spots were frequently detected in the enterocytes covering the
intestinal mucosa in close proximity of colon cancer. In the
same study, this peculiar immunohistochemical pattern was also
found in cells showing the morphological changes typical of
colon dysplasia. These findings suggest that Tb4 translocation
from one cytoplasmic compartment to another could play a
possible role in colon carcinogenesis. The significance of Tb4
translocation to the perinuclear regions, putatively to the trans-
Golgi network, remains at the best of our knowledge unknown.
Our data confirm that Tb4 may change its subcellular
localization in different environmental conditions. In this study,
the perinuclear spot-like pattern of immunoreactivity was
exclusively found in cells under stress, here represented by cells
growing in a medium without serum, or in cells living more than
three days in complete medium. Taken together, these data
indicate cytoplasmic translocation from cytoplasmic vacuoles
towards the perinuclear regions as a defense mechanism of
HepG2 cells against environmental changes causing cell stress.
The intimate mechanism by which Tb4 reaches the trans-Golgi
network, given the reported absence of a signal peptide in this
protein, remains unknown [30].
The second most important finding of this work is the nuclear
reactivity of the peptide, appearing as multiple Tb4-reactive
roundish spots dispersed throughout the entire nuclear envelop.
This phenomenon was observed late, at 84 h, in culture cells
growing in complete medium, and much earlier, at 48 h, in cells
growing in the absence of serum. The nuclear positivity seems to
be related to the starvation-induced stress; in fact, when the old
complete medium was substituted with a fresh one, and serum-
deprived cells received the entire medium, the ‘‘normal’’
immunocytochemical cytoplasmic pattern was restored, and the
peptide was not anymore detected at the nuclear level.
The ability of Tb4 to cross the nuclear membrane was first
reported in a study in which the peptide was injected in Xenopus
laevis oocytes, reaching both nuclear and cytoplasmic compart-
ments [14]. The ability of Tb4 to change its localization
according to different external stimuli was also described in
IEC-6 cells. In untreated control cells, the peptide was restricted
to the cytoplasm, whereas following cell depletion of poly-
amines, cytoplasmic expression decreased, paralleled by the
appearance of nuclear staining for Tb4 [16]. Nuclear localiza-
tion of Tb4, always associated with its cytoplasmic expression,
has been reported in another cell line, the human mammary
carcinoma MCF-7 [15]. In that study, authors suggested that
Tb4 might be shuttled into the nucleus utilizing an active
transport mechanism, requiring an unidentified soluble cyto-
plasmic factor. Recently, this factor has been reported to be
identified in the human MLH1, a key enzyme of DNA
mismatch repair with several additional functions, including
the intranuclear transport of Tb4 [31].
On the other hand, a passive but regulated diffusion has been
proposed as the mechanism that could explain the ability of Tb4
to shuttle into the nucleus [17]. According to this study, the Tb4
cytoplasmic-nuclear diffusion might be due to changes in the
barrier function of the nuclear pores [17].
Regarding the complex trafficking of the Tb4 from the
cytoplasm towards the nucleus here we provide new findings:
based on our immunocytochemical and biochemical data. Nuclear
translocation of Tb4 seems to be localized in the nuclear envelope
and not inside of the nucleus.
Mass spectrometry analysis of the nuclear proteins fraction
seems to confirm that Tb4 is not detectable inside of the nucleus
and, if present, it is under the detection limits of the HPLC-ESI-
MS technique in use. This finding is confirmed by the peculiar
immunocytochemical pattern of nuclear immunostaining, charac-
terized by a punctuated reactivity, highly suggestive of a Tb4
localization in the nuclear pores.
Regarding the significance of nuclear translocation of Tb4, it
has been suggested that this actin-binding peptide could function
as a modulator of gene transcription [32]. Interestingly, it was
recently suggested that Tb4 may be involved in the bidirectional
movement of specific proteins between nucleus and cytoplasm. In
that study, Tb4 has been shown to regulate nuclear translocation
of multiple proteins with a consequent modulation of the
inflammatory response [11].
The pattern of nuclear reactivity for Tb4 here reported confirm
this hypothesis, and suggest that Tb4 localization in nuclear pores
could play a relevant role in the regulation of the barrier function
of nuclear pores [17].
Another interesting finding of our study is represented by the
different pattern of Tb4 immunoreactivity in mitotic cells as
compared to culture cells in a resting phase. Cells undergoing
mitosis showed a predominant homogeneous staining pattern
diffuse to the entire cytoplasm, contrasting with the granular or
with the spot-like immunostaining detected in resting cells. The
marked differences in Tb4 staining pattern in mitotic cells could
indicate a translocation of the peptide from vacuoles towards the
cytoskeleton. Further studies on Tb4 subcellular localization at the
ultramicroscopic level might shed light on the intimate significance
of these lasts observations.
Taken all together, these data clearly show the ability of Tb4
to move from one cytoplasmic domain to the another, and to
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shuttle from the cytoplasm towards the nuclear membrane and
back, depending on changes of environmental conditions.
Further studies are needed in order to better explain the
intimate molecular mechanisms that are at the basis of this
translocation.
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